Overview
Mohammed Sabbagh is an Oncologist and a Hematologist in Georgetown, Texas. Dr. Sabbagh is rated as an Advanced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Myelodysplastic Syndrome (MDS), Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, and Wilms Tumor. Dr. Sabbagh is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3201 S Austin Ave, Suite 315, Georgetown, TX 78626
Scott And White Clinic
Sherronda Henderson is an Oncologist in Temple, Texas. Dr. Henderson is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. Her top areas of expertise are Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Bone Marrow Aspiration, and Endoscopy. Dr. Henderson is currently accepting new patients.
Texas Oncology PA
Beth Hellerstedt is a Hematologist Oncology specialist and an Oncologist in Round Rock, Texas. Dr. Hellerstedt is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Urothelial Cancer, and Familial Colorectal Cancer. Dr. Hellerstedt is currently accepting new patients.
Texas Oncology PA
Nihar Patel is a Hematologist Oncology specialist and an Oncologist in Round Rock, Texas. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Colorectal Cancer, Lynch Syndrome, and Bone Marrow Aspiration. Dr. Patel is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myelodysplastic Syndrome (MDS)Dr. Sabbagh isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Adult Soft Tissue SarcomaDr. Sabbagh isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Autoimmune Hemolytic AnemiaDr. Sabbagh isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Breast CancerDr. Sabbagh isAdvanced. Learn about Breast Cancer.
- Chromophobe Renal Cell CarcinomaDr. Sabbagh isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Sabbagh isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Sabbagh isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Sabbagh isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Sabbagh isExperienced. Learn about Acute Mountain Sickness.
- Acute Myelomonocytic LeukemiaDr. Sabbagh isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Sabbagh isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Sabbagh isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Sabbagh isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.